KR900000076A - 딜티아젬(diltiazem) 공급용의 제형(dosage form) - Google Patents
딜티아젬(diltiazem) 공급용의 제형(dosage form) Download PDFInfo
- Publication number
- KR900000076A KR900000076A KR1019880011405A KR880011405A KR900000076A KR 900000076 A KR900000076 A KR 900000076A KR 1019880011405 A KR1019880011405 A KR 1019880011405A KR 880011405 A KR880011405 A KR 880011405A KR 900000076 A KR900000076 A KR 900000076A
- Authority
- KR
- South Korea
- Prior art keywords
- formulation
- diltiazem
- wall
- molecular weight
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 장시간에 걸쳐 위장계에 유용한 약제 딜티아젬(drug diltiazem)을 구강투여하도록 형성되고 칫수를 맞춘 삼투제제로 만들어진 제형(dosage form)의 도면.
제2a도 및 제2b도는 제형의 구조를 설명하기 위해 제형의 벽부분을 제거한 제1도의 제형을 부분적으로 개방한 도면.
제3도는 본 발명에 의해 구비된 제형에 대한 딜티아젬의 방출속도를 설명하는 그래프.
제4도는 24시간에 걸쳐 방출누적된 딜티아젬의 량을 설명하는 그래프.
* 도면의 주요부분에 대한 부호의 설명
10 : 제형(dosage form) 11 : 몸체부재
12 : 벽 13 : 통로
14 : 구획 15 : 딜티아젬
16 : 조성물
Claims (8)
- (a) 둘레를 싸고 형성하는 벽과; (b) 구획(compartment)과; (c) 딜티아젬과 그의 제약학적으로 허용가능한 염, 2, 500, 000-4, 000, 000의 분자량을 포함하는 0.5중량%-15중량%의 폴리아크릴산, 4, 000, 000-5, 500, 000의 분자량을 포함하는 0.5중량%-20중량%의 폴리(에틸렌옥시드), 35, 000-40, 000의 분자량을 포함하는 0.5중량%의 폴리(비닐 필로리돈)으로 구성된 그룹으로부터 선택된 성분을 70중량%-96중량%를 포함하는 상기 구획속의 딜티아젬 조성물과; (d) 6, 200-7, 500, 000의 분자량을 포함하는 70중량%-95중량%의 폴리(에틸렌옥시드), 9, 000-16, 000의 분자량을 포함하는 1중량%-15중량%의 히드록시프로필메틸셀룰로오스를 포함하는 상기 구획내의 푸쉬 조성물(push composition)과; (e) 상기 장치로부터 딜티아젬을 공급하기 위한 상기 벽내의 적어도 하나의 통로를 포함하는 딜티아젬공급용 제형.
- 제1항에 있어서, 딜티아젬이 시간당 공급량을 실질적으로 영차 비율(zero order rate)로 공급됨을 특징으로 하는 제형.
- 제1항에 있어서, 벽이 셀룰로오스 아세테이트를 포함하는 제형.
- 제1항에 있어서, 벽이 히드록시프로필메틸셀룰로오스를 포함하는 제형.
- 제1항에 있어서, 벽이 39.8%의 아세틸 함량을 가지는 셀룰로오스 아세테이트를 포함하는 제형.
- 제1항에 있어서, 벽이 에틸 셀룰로오스를 포함하는 제형.
- 제1항에 있어서, 벽이 적어도 부분적으로 미세다공성 조성물을 포함하는 제형.
- 제1항에 있어서, 푸쉬 조성물이 염화나트륨을 포함하는 제형.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/201,519 US4859470A (en) | 1988-06-02 | 1988-06-02 | Dosage form for delivering diltiazem |
US07/201,519 | 1988-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900000076A true KR900000076A (ko) | 1990-01-30 |
KR960006062B1 KR960006062B1 (ko) | 1996-05-08 |
Family
ID=22746162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880011405A KR960006062B1 (ko) | 1988-06-02 | 1988-09-02 | 딜티아젬(diltiazem) 공급용의 제형(dosage form) |
Country Status (25)
Country | Link |
---|---|
US (1) | US4859470A (ko) |
JP (1) | JP2590226B2 (ko) |
KR (1) | KR960006062B1 (ko) |
AR (1) | AR241635A1 (ko) |
AT (1) | AT394311B (ko) |
AU (1) | AU612398B2 (ko) |
BE (1) | BE1001935A3 (ko) |
CA (1) | CA1311687C (ko) |
CH (1) | CH675208A5 (ko) |
DE (1) | DE3829941C2 (ko) |
DK (1) | DK175396B1 (ko) |
ES (1) | ES2008813A6 (ko) |
FI (1) | FI92553C (ko) |
FR (1) | FR2632306B1 (ko) |
GB (1) | GB2219205B (ko) |
GR (1) | GR1000197B (ko) |
IE (1) | IE61861B1 (ko) |
IT (1) | IT1223799B (ko) |
LU (1) | LU87327A1 (ko) |
MX (1) | MX174157B (ko) |
NL (1) | NL194747C (ko) |
NO (1) | NO174766C (ko) |
PT (1) | PT88405B (ko) |
SE (1) | SE503508C2 (ko) |
ZA (1) | ZA886436B (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
US5030452A (en) * | 1989-01-12 | 1991-07-09 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
US5108756A (en) * | 1989-01-12 | 1992-04-28 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
US5112614A (en) * | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser |
US5208037A (en) * | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
US6283951B1 (en) * | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
US6524620B2 (en) | 1998-07-20 | 2003-02-25 | Andrx Pharmaceuticals, Inc. | Diltiazem controlled release formulation and method of manufacture |
US6562375B1 (en) | 1999-08-04 | 2003-05-13 | Yamanouchi Pharmaceuticals, Co., Ltd. | Stable pharmaceutical composition for oral use |
CN1193792C (zh) * | 1999-08-04 | 2005-03-23 | 山之内制药株式会社 | 稳定的口服医药组合物 |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US6753011B2 (en) | 2000-01-14 | 2004-06-22 | Osmotica Corp | Combined diffusion/osmotic pumping drug delivery system |
US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
AR040682A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
EP2431027A1 (en) | 2004-08-13 | 2012-03-21 | Boehringer Ingelheim International GmbH | Extended release pellet formulation containing Pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
BRPI0513847A (pt) | 2004-08-13 | 2008-05-20 | Boehringer Ingelheim Int | formulação de comprimido de liberação extendida contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e uso do mesmo |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
IT1153487B (it) * | 1982-04-15 | 1987-01-14 | Prophin Lab Spa | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli |
NZ206600A (en) * | 1983-05-11 | 1987-01-23 | Alza Corp | Osmotic drug delivery device |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
IT1206166B (it) * | 1984-07-26 | 1989-04-14 | Sigma Tau Ind Farmaceuti | Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione |
US4624847A (en) * | 1985-04-22 | 1986-11-25 | Alza Corporation | Drug delivery device for programmed delivery of beneficial drug |
EP0205336B1 (en) * | 1985-06-11 | 1991-09-11 | Teijin Limited | Oral sustained release pharmaceutical preparation |
US4753802A (en) * | 1986-03-19 | 1988-06-28 | Alza Corporation | Verapamil dosage form |
ES2032205T3 (es) * | 1986-11-14 | 1993-01-16 | Ciba-Geigy Ag | Procedimiento para la obtencion de un sistema osmotico oral para la administracion de metoprolol. |
-
1988
- 1988-06-02 US US07/201,519 patent/US4859470A/en not_active Expired - Lifetime
- 1988-08-25 AU AU21527/88A patent/AU612398B2/en not_active Expired
- 1988-08-29 NO NO883838A patent/NO174766C/no not_active IP Right Cessation
- 1988-08-30 ZA ZA886436A patent/ZA886436B/xx unknown
- 1988-08-30 GB GB8820461A patent/GB2219205B/en not_active Expired - Lifetime
- 1988-08-31 LU LU87327A patent/LU87327A1/fr unknown
- 1988-08-31 IE IE264288A patent/IE61861B1/en not_active IP Right Cessation
- 1988-09-01 FR FR888811441A patent/FR2632306B1/fr not_active Expired - Lifetime
- 1988-09-01 AT AT0214588A patent/AT394311B/de not_active IP Right Cessation
- 1988-09-01 DK DK198804856A patent/DK175396B1/da not_active IP Right Cessation
- 1988-09-02 FI FI884057A patent/FI92553C/fi not_active IP Right Cessation
- 1988-09-02 SE SE8803085A patent/SE503508C2/sv not_active IP Right Cessation
- 1988-09-02 ES ES8802715A patent/ES2008813A6/es not_active Expired
- 1988-09-02 IT IT67791/88A patent/IT1223799B/it active
- 1988-09-02 NL NL8802181A patent/NL194747C/nl not_active IP Right Cessation
- 1988-09-02 PT PT88405A patent/PT88405B/pt not_active IP Right Cessation
- 1988-09-02 BE BE8801003A patent/BE1001935A3/fr not_active IP Right Cessation
- 1988-09-02 JP JP63220304A patent/JP2590226B2/ja not_active Expired - Lifetime
- 1988-09-02 AR AR88311836A patent/AR241635A1/es active
- 1988-09-02 KR KR1019880011405A patent/KR960006062B1/ko not_active IP Right Cessation
- 1988-09-02 DE DE3829941A patent/DE3829941C2/de not_active Expired - Lifetime
- 1988-09-02 CH CH3301/88A patent/CH675208A5/de not_active IP Right Cessation
- 1988-09-02 CA CA000576410A patent/CA1311687C/en not_active Expired - Lifetime
- 1988-09-02 GR GR880100574A patent/GR1000197B/el not_active IP Right Cessation
-
1992
- 1992-04-08 MX MX9201606A patent/MX174157B/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900000076A (ko) | 딜티아젬(diltiazem) 공급용의 제형(dosage form) | |
KR930701156A (ko) | 경시적 약물 전달을 위한 제형 | |
ATE151285T1 (de) | Orale arzneimittel mit kolonspezifischer freisetzung | |
KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
KR920702216A (ko) | 아세틸 d-카르니틴의 녹내장 치료에의 용도 | |
KR870008594A (ko) | 베라파밀제형 | |
KR880002502A (ko) | 산에 민감한 유익한 약제의 투여용 제형(劑形) | |
AR012995A1 (es) | Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de medicamentos y composiciones farmaceuticas que contienedichos compuestos. | |
CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
BR9609696A (pt) | Administração oral unidades separadas | |
KR880009634A (ko) | 슈도에페드린 브롬페니라민 요법의 개량 | |
KR870008583A (ko) | 슈도에페드린, 브롬페니라민 요법 | |
KR960000247A (ko) | 사이클로스포린a 함유 조성물 및 그의 제조방법 | |
ES2098496T3 (es) | Forma medicamentosa aplicable por via peroral para el tratamiento de estados de insuficiencia de dopamina en el sistema nervioso central. | |
ATE259823T1 (de) | Tricyclische erythromycinderivate | |
ES2131517T3 (es) | Composicion farmaceutica de uso oftalmologico que comprende un agente antiinflamatorio no esteroide y un agente anticongestivo. | |
CO4230093A1 (es) | Derivados del indol y sus usos medicos | |
KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
IT1301968B1 (it) | Derivati di eritromicina ad attivita' antibiotica | |
KR870009716A (ko) | 클로르페니라민 제형 | |
KR920019365A (ko) | 디리트로마이신을 함유하는 약학 제형 | |
EE9600202A (et) | Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm | |
KR880005944A (ko) | 삼투성 연속 분배 경구용 전달 시스템 | |
ES2064104T3 (es) | Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral. | |
ATE212840T1 (de) | Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020430 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |